We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Advanced Medical Solutions Group Plc | LSE:AMS | London | Ordinary Share | GB0004536594 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
2.40 | 1.24% | 195.40 | 194.80 | 195.60 | 195.60 | 192.00 | 192.40 | 342,131 | 16:35:23 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Plastics,resins,elastomers | 126.21M | 15.89M | 0.0732 | 26.67 | 424M |
TIDMAMS
RNS Number : 5739H
Advanced Medical Solutions Grp PLC
01 December 2015
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) -------------------------------------------------- 1. Identity of the issuer or the underlying Advanced Medical Solutions Group issuer PLC of existing shares to which voting rights are attached: (ii) --------------------------------------------------- --------------------------------------- 2 Reason for the notification (please tick the appropriate box or boxes): -------------------------------------------------------------------------------------------- An acquisition or disposal of voting rights .. ---------------------------------------------------------------------------------- -------- An acquisition or disposal of qualifying financial instruments .. which may result in the acquisition of shares already issued to which voting rights are attached ---------------------------------------------------------------------------------- -------- An acquisition or disposal of instruments with similar economic .. effect to qualifying financial instruments ---------------------------------------------------------------------------------- -------- An event changing the breakdown of voting rights .. ---------------------------------------------------------------------------------- -------- Other (please Baseline notification required as a result of S specify): the implementation of changes to the transparency directive ------------------ -------------------------------------------------------------- -------- 3. Full name of person(s) subject BlackRock, Inc. to the notification obligation: (iii) ------------------------------------------ ------------------------------------------------ 4. Full name of shareholder(s) (if different from 3.):(iv) ------------------------------------------ ------------------------------------------------ 5. Date of the transaction and date 26 November, 2015 on which the threshold is crossed or reached: (v) ------------------------------------------ ------------------------------------------------ 6. Date on which issuer notified: 30 November, 2015 ------------------------------------------ ------------------------------------------------ 7. Threshold(s) that is/are crossed Baseline notification required as a or result of the implementation of changes reached: (vi, vii) to the transparency directive; BlackRock Inc. shares and voting rights remain above the previously disclosed threshold of 5% ------------------------------------------ ------------------------------------------------ 8. Notified details: ------------------------------------------------------------------------------------------------------------------------ A: Voting rights attached to shares (viii, ix) ------------------------------------------------------------------------------------------------------------------------ Class/type Situation previous Resulting situation after the triggering of to the triggering transaction shares transaction if possible using the ISIN CODE ------------- -------------------------------------- ----------------------------------------------------------------- Number Number Number Number of voting % of voting rights of of of rights (x) Shares Voting shares Rights ------------- ---------------- -------------------- --------- ----------------------- ----------------------------- Direct Direct Indirect Direct Indirect (xi) (xii) ------------- ----- ------- ------ ------ ---- --------- ---------- ----------- ------------- -------------- GB0004536594 13,750,749 13,750,749 N/A N/A 15,689,669 N/A 7.51% ---------------- -------------------- --------- ---------- ----------- ------------- -------------- B: Qualifying Financial Instruments ------------------------------------------------------------------------------------------------------------------------ Resulting situation after the triggering transaction ------------------------------------------------------------------------------------------------------------------------ Type of financial Expiration Exercise/ Number of voting % of voting instrument date (xiii) Conversion Period rights that may rights (xiv) be acquired if the instrument is exercised/ converted. ---------------------- --------------- ---------------------------- --------------------------- -------------------- Securities Lending 315,954 0.15% ---------------------- --------------- ---------------------------- --------------------------- -------------------- C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) ------------------------------------------------------------------------------------------------------------------------ Resulting situation after the triggering transaction ------------------------------------------------------------------------------------------------------------------------ Type of Exercise Expiration Exercise/ Number of voting % of voting rights financial price date (xvii) Conversion rights instrument (xix, xx) instrument period refers to (xviii) --------------- -------------- -------------- --------------- --------------------------- ------------------------- CFD 446,585 Nominal Delta --------------- -------------- -------------- --------------- --------------------------- ------------ ----------- 0.21% 0.21% ------------- ----- ------- ------ ------ ---- ------- --- ----- ----------- ------------ ----------- Total (A+B+C) ------------------------------------------------------------------------------------------------------------------------ Number of voting rights Percentage of voting rights -------------------------------------------------------------- -------------------------------------------------------- 16,452,208 7.87% -------------------------------------------------------------- -------------------------------------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: (xxi) -------------------------------------------------------------------------------------- See Annex Proxy Voting: -------------------------------------------------------------------------------------- 10. Name of the proxy holder: ----------------------------------------------------- ------------------------------- 11. Number of voting rights proxy holder will cease to hold: ----------------------------------------------------- ------------------------------- 12. Date on which proxy holder will cease to hold voting rights: ----------------------------------------------------- ------------------------------- 13. Additional information: BlackRock Regulatory Threshold Reporting Team ---------------------------------------- -------------------------------------------- 14. Contact name: Gareth Slade ---------------------------------------- -------------------------------------------- 15. Contact telephone number: 020 7743 3650 ---------------------------------------- -------------------------------------------- Name % of voting % of voting rights Total of both rights if it through financial if it equals equals or is instruments if or is higher higher than it equals or than the notifiable the notifiable is higher than threshold threshold the notifiable threshold ----------------------------------- ---------------- ------------------- --------------------- BlackRock, Inc.
(MORE TO FOLLOW) Dow Jones Newswires
December 01, 2015 07:04 ET (12:04 GMT)
1 Year Advanced Medical Solutions Chart |
1 Month Advanced Medical Solutions Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions